6-100390248-T-A
Position:
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2
The NM_005068.3(SIM1):c.*113A>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0387 in 1,174,356 control chromosomes in the GnomAD database, including 1,051 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.030 ( 103 hom., cov: 32)
Exomes 𝑓: 0.040 ( 948 hom. )
Consequence
SIM1
NM_005068.3 3_prime_UTR
NM_005068.3 3_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.522
Genes affected
SIM1 (HGNC:10882): (SIM bHLH transcription factor 1) SIM1 and SIM2 genes are Drosophila single-minded (sim) gene homologs. SIM1 transcript was detected only in fetal kidney out of various adult and fetal tissues tested. Since the sim gene plays an important role in Drosophila development and has peak levels of expression during the period of neurogenesis,it was proposed that the human SIM gene is a candidate for involvement in certain dysmorphic features (particularly the facial and skull characteristics), abnormalities of brain development, and/or cognitive disability of Down syndrome. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 6-100390248-T-A is Benign according to our data. Variant chr6-100390248-T-A is described in ClinVar as [Benign]. Clinvar id is 354672.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0296 (4514/152326) while in subpopulation NFE AF= 0.0429 (2916/68020). AF 95% confidence interval is 0.0416. There are 103 homozygotes in gnomad4. There are 2143 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 4514 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SIM1 | NM_005068.3 | c.*113A>T | 3_prime_UTR_variant | 12/12 | ENST00000369208.8 | NP_005059.2 | ||
SIM1 | NM_001374769.1 | c.*113A>T | 3_prime_UTR_variant | 12/12 | NP_001361698.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SIM1 | ENST00000369208.8 | c.*113A>T | 3_prime_UTR_variant | 12/12 | 1 | NM_005068.3 | ENSP00000358210 | P1 | ||
SIM1 | ENST00000262901.4 | c.*113A>T | 3_prime_UTR_variant | 11/11 | 1 | ENSP00000262901 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0297 AC: 4516AN: 152208Hom.: 103 Cov.: 32
GnomAD3 genomes
AF:
AC:
4516
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.0401 AC: 40951AN: 1022030Hom.: 948 Cov.: 13 AF XY: 0.0399 AC XY: 20498AN XY: 514322
GnomAD4 exome
AF:
AC:
40951
AN:
1022030
Hom.:
Cov.:
13
AF XY:
AC XY:
20498
AN XY:
514322
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0296 AC: 4514AN: 152326Hom.: 103 Cov.: 32 AF XY: 0.0288 AC XY: 2143AN XY: 74492
GnomAD4 genome
AF:
AC:
4514
AN:
152326
Hom.:
Cov.:
32
AF XY:
AC XY:
2143
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Obesity due to SIM1 deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 12, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at